Imperial Brands' Buyback: Can Share Count Reductions Justify a Premium or Is the EPS Pop Already Priced In?

The latest share cancellation confirms the scale of Imperial's capital return plan. On 5 March, the company bought 662,265 ordinary shares at an average price of 3,185 pence for cancellation. This is part of a program that management has explicitly tied to a major shareholder return target. The company expects total shareholder returns to exceed £2.7 billion over the current financial year, which includes the £1.45 billion buyback and a 4.5% increase to the dividend.

This isn't a surprise move; it's a continuation of an aggressive strategy. Since 2021, the company has generated £11.6bn in free cash flow, funding a cumulative capital return of £10 billion. The size of the 2026 buyback, however, signals a stronger commitment. At £1.45 billion, it is higher than in previous years, indicating management's confidence in its cash generation and a deliberate effort to enhance shareholder value through a reduced share count.

The market has clearly priced in this level of return. The buyback is a large, expected signal of confidence, not a new surprise. The real question now is whether the stock's recent performance reflects all of this, or if there's still an expectation gap to close.

Expectations vs. Reality: The EPS Impact

The market has already baked the EPS benefits of the buyback into the stock price. The company's guidance for the current year explicitly factors in the share count reduction as a key driver. Management expects high-single-digit adjusted EPS growth, a target that is supported by both profit expansion and the ongoing buyback programme. This isn't a hidden catalyst; it's a line item in the forward view.

The setup for this growth is clear. In the prior fiscal year, the company delivered 4% revenue growth and 9% EPS expansion. The 9% EPS jump was a direct result of profit gains and the initial impact of share reductions. The FY2026 plan aims to replicate that dynamic, with the buyback continuing to act as a multiplier on earnings. The stock's recent performance, trading near 3,140p, reflects this anticipated benefit.

Yet, the valuation tells the real story. With a price-to-earnings ratio of 12.9, Imperial trades at the low end of its historical range. This suggests the market is not rewarding the company for the EPS tailwind from the buyback-it is already priced in. The stock is moving on other factors, like the sheer scale of the capital return and the stability of its cash flows, rather than on incremental EPS beats from share cancellation.

The bottom line is that the expectation gap here is not about the mechanics of EPS growth. It's about the premium. The market has priced in the positive EPS impact of the buyback, leaving little room for a surprise pop if guidance is met. The real arbitrage opportunity, if it exists, lies elsewhere-in whether the company can exceed the profit growth part of the equation, or if the buyback itself is being executed at prices that signal deeper confidence than the current P/E implies.

Market Reaction and Analyst Sentiment

The market's verdict on Imperial's capital return is clear: it's a Buy, but with a cautious note. Analysts maintain a Buy rating with a £3,500.00 price target, which implies meaningful upside from recent levels around 3,127p. This consensus view is built on the company's undeniable strengths, particularly its strong cash generation and an attractive dividend yield. The £1.45 billion buyback is a key pillar in this thesis, seen as a disciplined use of the company's robust free cash flow.

Yet, the analyst narrative is not without its caveats. The sector's regulatory challenges remain a persistent overhang, tempering the bullish case. This reflects a market that has priced in the buyback's benefits but is still weighing the long-term risks. The stock's valuation tells the same story. Despite the aggressive returns, Imperial trades at a price-to-earnings ratio of 12.9, near its historical low. This is the clearest signal that the market has already discounted the EPS boost from the share count reduction. The stock is moving on other factors, like the sheer scale of the capital return and the stability of its cash flows, rather than on incremental EPS beats from share cancellation.

The bottom line is a market that sees the buyback as a necessary, expected part of the story, not a surprise catalyst. The average price target suggests analysts believe the company can navigate its challenges and deliver on its cash flow promise, but they are not rewarding it for simply executing a plan the market has already priced in. The expectation gap here is not about the buyback itself, but about whether the company can exceed the profit growth part of its guidance to justify a higher multiple.

Catalysts and Risks: Beyond the Buyback

The market has priced in the buyback, but the stock's future path hinges on a tug-of-war between specific growth catalysts and persistent headwinds. The company's forward view is built on a clear, if narrow, set of drivers.

The primary catalyst is a targeted market share recovery. Management expects market share gains in the US, Germany and Australia, to broadly offset declines in Spain and the UK. This is the core of the "challenger" strategy. Success here would validate the company's shift to a more consumer-centric model and provide a tangible counter-narrative to the long-term decline in its core European markets. The company's NGP business, which includes vapes and oral nicotine, is also a growth lever, with double-digit net revenue growth expected for the year. This is critical for building a future beyond combustibles.

Yet, the major risk is the continued erosion in those core markets. The company has already seen market share declines in the UK and Spain, two of its priority markets. This isn't a minor blip; it's a structural challenge that has persisted for years. Any acceleration in these declines would directly undermine the offset strategy and pressure the pricing power that currently supports profits.

Regulatory threats add another layer of uncertainty. The UK government's phased banning of combustible sales represents a specific, near-term threat that could accelerate volume declines. This policy is a known risk, but its exact timing and impact remain a wildcard that the market must weigh against the company's cash flow resilience.

The financial bedrock for navigating this volatility is the company's exceptional cash generation. Management expects at least £2.2bn of free cash flow in 2026. This robust, predictable flow is what funds the £1.45 billion buyback and the dividend increase, regardless of near-term earnings swings. It provides the flexibility to execute the capital return plan while investing in the NGP business and managing the factory transition in Germany.

The bottom line is that the stock is now a bet on execution. The buyback is a given; the market has priced it in. The real expectation gap is whether the company can deliver on its share gain targets and NGP growth to justify a higher valuation, or if the regulatory and volume headwinds will prove too powerful. The strong cash flow is the safety net, but it doesn't guarantee a premium.